LIVING WITH IT WORKING WITH IT TREATING IT
“Chronic pulmonary aspergillosis (CPA) is a severe fungal infection with a high morbidity and mortality, and is usually seen in immunocompetent patients with respiratory disorders. Clinical presentation is nonspecific and often overlaps with the symptoms and the radiological pattern caused by the underlying disease. Clinical management of CPA is further hampered by limited information about the epidemiology, disease dynamics, sensitivity and specificity of different mycological tests, mechanisms of antifungal resistance, efficient treatment and management strategies. In order to contribute to a better understanding and to improve CPA patient management and outcome, we established in March 2017 the Chronic Pulmonary Aspergillosis Network (CPAnet), a self-organized multinational research collaboration to promote clinically oriented research in the field of CPA by sharing and developing research ideas and protocols. (Godet C. et al. JAC 2018).”
Our most recent newsletters (since August 2018) can be found here.
An archive of our older newsletters (dating back to 2006) can be found here.